|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 September 2022 |
|
Main ID: |
NCT03926702 |
|
Date of registration:
|
22/04/2019 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Tau Imaging With JNJ067
|
|
Scientific title:
|
Tau Imaging With JNJ067 |
|
Date of first enrolment:
|
June 18, 2019 |
|
Target sample size:
|
18 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03926702 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
|
|
Phase:
|
Early Phase 1
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Healthy Volunteers: Subjects must be aged 50 and over. These individuals will all be
of good general medical health with no neurological diseases and capable of providing
informed consent.
- Patients: Subjects must be aged 50 and over. Patients will meet diagnostic criteria at
UCSF for Alzheimer's disease (AD), mild cognitive impairment (MCI), or progressive
supranuclear palsy (PSP).
Exclusion Criteria:
- Any medical contraindications to an MRI scan
- A pacemaker
- Metal clips in brain or tattoos above neck
- Metallic implants or shrapnel in body
- Any body jewelry or piercings that are not removable
- A history of claustrophobia
- A known major systemic disease
- A history of a psychiatric disorder
- A history of substance abuse (prescription or non-prescription) within the past 5
years
- A current weight of less than 45 kilograms (100 pounds)
- Difficulty in urinating or emptying the bladder
- Under age 50
- Participating in an experimental radiotracer study
- Subjects must be fluent English speakers
Age minimum:
50 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Progressive Supranuclear Palsy
|
|
Alzheimer Disease
|
|
Mild Cognitive Impairment
|
|
Intervention(s)
|
|
Drug: Radiopharmaceuticals
|
|
Primary Outcome(s)
|
|
Positron-emission tomography (PET) scan results
[Time Frame: 3 hours]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|